FONAR Corporation

FONAR Corporation

FONR
FONAR CorporationUS flagNASDAQ Capital Market
19.09
USD
- -
- -
117.76MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
8.11
10.72
10.73
11.4
11.92
12.96
13.72
13.3
13.82
14.89
15.08
16.2
16.85
17.08
Basic EPS, GAAP
1.36
1.55
1.91
2.56
2.86
3.53
2.3
1.22
1.5
1.81
1.37
1.59
1.28
1.03
Free Cash Flow per Basic Share
1.03
1.96
2.02
2.45
2.11
2.52
2.51
1.98
2.19
1.63
1.55
2.09
1.2
0.74
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-26.34
-23.35
-21.19
-18.75
-15.43
-12.69
-10.14
-8.72
-7.07
-5.12
-3.7
-2.14
-0.85
0.11
Tangible Book Value per Share
3.98
5.26
6.23
7.73
11.05
14.74
17.21
18.34
19.53
21.1
21.89
23.56
24.68
25.51
Basic Weighted Avg Shares
6
6
6
6
7
6
6
6
7
7
7
6
6
6
Sales/Revenue/Turnover
49
69
69
73
78
82
87
86
90
98
99
103
104
105
Operating Margin (%)
15.33
17.96
18.68
19.57
24.47
24.15
25.39
15.93
19.01
22.55
14.99
16.07
11.12
9.05
Depreciation Expense
2
4
4
3
4
4
4
5
6
9
9
5
5
5
Net Income, GAAP
9
10
13
16
20
21
15
8
10
12
9
11
8
7
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
8.91
17.28
22.6
24.31
23.05
26.83
22.55
21.94
Profit Margin (%)
17.66
15.18
18.7
21.43
25.14
26.04
17.57
9.62
11.35
12.75
9.5
10.27
7.99
6.35
Working Capital
17
22
25
25
39
52
71
77
89
102
110
122
128
132
LT Debt
13
8
6
2
- -
- -
- -
32
31
34
33
38
35
35
Total Equity
38
46
51
61
83
102
118
126
135
146
151
157
160
164
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
20.4
8.15
8.11
9.47
6.11
6.24
4.5
3.68
Return on Capital (%)
- -
- -
- -
- -
- -
- -
-14.81
-11.74
-39.91
-114.91
210.43
57.65
30.07
18.97
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
4
4
4
LT Borrowings
- -
- -
- -
LT Finance Leases
36
36
35
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
6
Market Capitalization
94
114
114

Working Capital

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
144
144
148
Cash, Cash Equivalents & STI
54
53
54
Accounts Receivable, Net
30
29
30
Inventories
3
3
3
Total Current Liabilities
17
14
16
Payables & Accruals
5
4
5
ST Debt
4
4
4
Deferred Revenue
5
5
5

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.63%
4.89%
2.12%
Free Cash Flow
-2.7%
-6.27%
-43.88%
Net Income, GAAP
-0.66%
2.54%
-21.13%
Sales/Revenue/Turnover
4.26%
4.06%
1.43%
Total Cash Common Dividend
-85.28%
3.18%
-19.22%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
26
25
26
26
103
2025
25
25
27
27
104
2026
26
26
26
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.61
0.56
0.28
- -
1.59
2025
0.47
0.3
0.39
- -
1.28
2026
0.35
0.32
0.25
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Timothy R. Damadian
Full Time Employees
520
Sector
Healthcare
Industry
Medical - Devices
Address
110 Marcus Drive Melville NY United States of America 11747
IPO Date
Oct 29, 1981
Website
fonar.com
Business
FONAR Corporation (NASDAQ: FONR) develops, manufactures, sells and services magnetic resonance imaging (MRI) scanners and provides physician management and diagnostic imaging services. The company offers its flagship FONAR UPRIGHT Multi-Position MRI (Stand-Up MRI), the world's only whole-body open MRI scanner capable of imaging patients in weight-bearing positions including standing, sitting, bending and lying down; related service and maintenance contracts; replacement parts; and innovations such as oblique imaging, multi-angle oblique scanning protocols and position imaging. Through its subsidiary Health Management Corporation of America (HMCA), FONAR delivers comprehensive management services encompassing administrative support, billing and collections, compliance consulting, IT services, equipment maintenance, purchasing and non-medical staffing to diagnostic imaging centers; HMCA owns and operates six diagnostic imaging facilities primarily in Florida and manages additional centers and multi-specialty practices in New York and Florida. Founded in 1978 by Dr. Raymond V. Damadian and headquartered in Melville, New York, FONAR pioneered the first commercial whole-body MRI scanner in 1980 and maintains global installations of approximately 300 MRI systems across regions including the United States, Europe, India, China, Korea, Australia, Saudi Arabia and Mexico. Recent developments include a distributor agreement with AIRS Medical in November 2023 for AI-powered MRI technology; non-binding "take-private" acquisition proposals in July 2025 from a management-led group including CEO Timothy R. Damadian offering $17.25 per share, representing a 27% premium to recent trading averages, under review by a special committee of independent directors; board appointments of independent directors Robert M. Carrino in July 2025 and others; and announcement of first quarter fiscal 2026 financial results in November 2025.

Company News

APIChat
  • FONAR Announces Financial Results for Fiscal 2026 Third Quarter and Nine-Month Period

  • FONAR Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of FONAR Corporation - FONR

  • Fonar (NASDAQ:FONR) Shares Cross Above 200-Day Moving Average – Should You Sell?

  • Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders?

  • Shareholder Alert: The Ademi Firm continues to investigate whether FONAR Corporation is obtaining a Fair Price for its Public Shareholders

  • Semperit Ag Hld (OTCMKTS:SEIGY) & Fonar (NASDAQ:FONR) Financial Review

  • Are CTGO, FONR, CWAN Obtaining Fair Deals for their Shareholders?

  • Fonar Announces Financial Results for The 2nd Quarter of Fiscal 2026

  • Fonar (NASDAQ:FONR) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell?

  • SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of FONAR Corporation

  • Fonar (NASDAQ:FONR) and Stagezero Life Sciences (OTCMKTS:SZLSF) Head-To-Head Comparison

  • FONAR Shareholder Notice: Kaskela Law Firm Announces Investigation into Proposed FONAR Corp. (NASDAQ: FONR) Buyout and Encourages Investors to Contact the Firm

  • FONAR Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of FONAR Corporation - FONR

  • SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of FONAR Corporation

  • Halper Sadeh LLC Encourages PEN, FONR, GDOT Shareholders to Contact the Firm to Discuss Their Rights

  • Halper Sadeh LLC Encourages FONR, OCFC, FFIC Shareholders to Contact the Firm to Discuss Their Rights

  • Halper Sadeh LLC Encourages VTYX, FONR, SNCY, FFIC Shareholders to Contact the Firm to Discuss Their Rights

  • Halper Sadeh LLC Encourages FONR, DBRG, ONTF Shareholders to Contact the Firm to Discuss Their Rights

  • $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger—DVAX, FONR, DBRG, and ONTF

  • SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of FONAR Corporation (NASDAQ: FONR)